BioSpace News Archive

Business

Ordaōs and NonExomics Announce Research Collaboration

Ordaōs partners with NonExomics to create customized mini-proteins.

September 28, 2022
·
3 min read
As part of its strategy for global growth and the enhancement of internal expertise, focusing on biotech, Olon is delighted to present its two-year plan for investment in the Settimo Torinese Biotech Centre (Italy)

The plan, worth €30 million, will be implemented over the following two-year period, with the aim of significantly expanding the capacity and expertise of the Settimo Torinese Biotech Hub.

September 28, 2022
·
1 min read
Drug Development

Odyssey Health, Inc. Announces Successful Completion of Phase I Clinical Trial for Concussion Drug

Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, today announces the completion of all cohorts for its Phase I Single Ascending Dosing (SAD) and Multiple Ascending Dosing (MAD) clinical trial.

September 28, 2022
·
5 min read
Business

Code Biotherapeutics Names David Anderson, PhD, as Chief Scientific Officer

Code Biotherapeutics today announces the appointment of David Anderson, PhD, as Chief Scientific Officer.

September 28, 2022
·
3 min read
Lone Star Bio

Gradalis to Host Key Opinion Leader Webinar on Unmet Medical Needs in Ovarian Cancer and the Company’s Immuno-Oncology Treatment, Vigil®

Gradalis today announced that it will host a key opinion leader (KOL) webinar on the current treatment landscape for ovarian cancer and Vigil ® , the company’s fully personalized, patient-specific cancer immunotherapy, on Monday, October 3, 2022 at 1:00 p.m. ET.

September 28, 2022
·
7 min read
Drug Development

Evommune Initiates Phase 2a Proof-of-Concept Clinical Trial to Evaluate EVO101 in Atopic Dermatitis

Evommune, Inc. today announced enrollment of the first patient in a Phase 2a proof-of-concept clinical trial evaluating EVO101, a novel small molecule inhibitor of interleukin 1 receptor-associated kinase 4 (IRAK4), in patients with atopic dermatitis (AD).

September 28, 2022
·
5 min read
Genetown

Precision Optics to Participate in the Lytham Partners Fall 2022 Investor Conference

Precision Optics Corporation, Inc. announced today that it will be participating in the Lytham Partners Fall 2022 Investor Conference taking place virtually on September 28-29, 2022.

September 28, 2022
·
3 min read
Biotech Beach

Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Academy of Ophthalmology Annual Meeting

Glaukos Corporation announced today that its technologies will be featured in various scientific programming at the American Academy of Ophthalmology (AAO) annual meeting, being held September 30 - October 3, 2022 in Chicago, IL.

September 28, 2022
·
8 min read
Organ on a Chip Market Size Worth USD 209.4 Million in 2028 | Emergen Research

According to the most recent report by Emergen Research, the size of the worldwide organ on a chip market is anticipated to reach USD 209.4 Million in 2028, growing at a steady CAGR of 28.1%.

September 28, 2022
·
8 min read
Increasing Number of Clinical Trials Ongoing to Avail Newer and Safer Treatment Options is Expected to Drive Lumbar Disc Disease Treatment Market Growth by 2030 | Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Lumbar Disc Disease Treatment Market – Forecast to 2030,’ thoroughly examines the Lumbar Disc Disease Treatment industry to provide essential data & information for the targeted readers.

September 28, 2022
·
6 min read